SOURCE: Foxit Corporation

Foxit Corporation

May 03, 2016 08:00 ET

Foxit PhantomPDF Certified Compliant With SAFE-BioPharma® Digital Signature Standard

Certification Addresses Critical Industry Need for Proof of Identity Associated With Digital Signatures on Regulatory Submissions

FREMONT, CA--(Marketwired - May 3, 2016) -  Foxit Software, a leading software provider of fast, affordable, and secure PDF solutions, today announced that Foxit PhantomPDF has been certified compliant with the SAFE-BioPharma® global digital identity standard. Compliance with the SAFE-BioPharma standard provides the strongest proof of the identity of the person who applied a digital signature to a submission to government regulators.

PhantomPDF is a full-featured, business-ready PDF solution that includes viewing, creation, editing, commenting, sharing, security, organization, exporting, OCR, security, form creation, and digital signature features. The flagship PhantomPDF Business edition offers an extensive range of usability and power features that meet the requirements of individual users, small businesses, and large enterprises.

"We are pleased to receive this important certification," said Susana De Abrew, in-house Regulatory Director at Foxit Software. "SAFE-BioPharma works closely with global regulatory agencies such as the US Food and Drug Administration and European Medicines Agency to ensure that its standard facilitates user compliance with 21CFR11 and regulatory requirements for digital signatures in Europe. Without this certification, digital signatures could not be adopted into this environment."

"PhantomPDF is a highly robust, validated, and secure PDF solution that is easy and cost-effective to use and now certified by SAFE-BioPharma to ensure that the highest standards in signature authentication are upheld," De Abrew added.

About SAFE-BioPharma

The SAFE-BioPharma standard was developed by the pharmaceutical industry with input from the Food and Drug Administration and the European Medicines Agency. SAFE-BioPharma is the pharmaceutical industry's only international standard for managing digital identities and for applying digital signatures to electronic documents. SAFE-BioPharma Association is the non-profit pharmaceutical industry coalition that manages the standard. For more information on the SAFE-BioPharma standard for digital identity and digital signatures used in life science and healthcare settings, visit http://www.safe-biopharma.org.

SAFE-BioPharma® is a trademark of SAFE-BioPharma Association. Use of this trademark requires approval from SAFE-BioPharma Association.

About Foxit Software

Foxit is a leading software provider of fast, affordable, and secure PDF solutions. Businesses and consumers increase productivity by using Foxit's cost-effective products to securely work with PDF documents and forms. Foxit is the #1 pre-installed PDF software, shipped on one-third of all new Windows PCs, including those from HP®, Acer, and ASUS®.

Foxit's Software Development Kits (SDKs) help developers reduce costs and improve time to market by easily integrating industry-leading PDF technology into application workflows. This technology shares the same underlying technology that powers Google's open-source PDFium project, as well as PDF reading in the Chrome browser and Android phones.

Winner of numerous awards, Foxit has over 325 million users and has sold to over 100,000 customers located in more than 200 countries. Since Foxit products are compliant with the ISO 32000-1/PDF 1.7 standard, they are compatible with existing PDF documents and forms.

Contact Information

  • Media Contact:

    Kevin Sugarman
    GlobalFluency
    408.677.5311
    Email Contact